The vision of the Western Connecticut Health Network’s (WCHN) Biomedical Research Institute (BRI) is to advance the health of the community by performing innovative translational research currently in human cancer and Lyme disease with the goal of improving standard of patient care …​ more

A recent newspaper article highlights the work of Dr. John Matignetti, a cancer geneticist at the Icahn School of Medicine at Mount Sinai in Manhattan, and the Director of the Western Connecticut Health Network’s Laboratory for Translational Research … more

The research paper discussed in the newspaper article is available here … more